159 related articles for article (PubMed ID: 9079677)
1. Structural determinants of the interaction between the erbB2 receptor and the Src homology 2 domain of Grb7.
Janes PW; Lackmann M; Church WB; Sanderson GM; Sutherland RL; Daly RJ
J Biol Chem; 1997 Mar; 272(13):8490-7. PubMed ID: 9079677
[TBL] [Abstract][Full Text] [Related]
2. Solution structure of the human Grb14-SH2 domain and comparison with the structures of the human Grb7-SH2/erbB2 peptide complex and human Grb10-SH2 domain.
Scharf PJ; Witney J; Daly R; Lyons BA
Protein Sci; 2004 Sep; 13(9):2541-6. PubMed ID: 15322292
[TBL] [Abstract][Full Text] [Related]
3. Identification of novel non-phosphorylated ligands, which bind selectively to the SH2 domain of Grb7.
Pero SC; Oligino L; Daly RJ; Soden AL; Liu C; Roller PP; Li P; Krag DN
J Biol Chem; 2002 Apr; 277(14):11918-26. PubMed ID: 11809769
[TBL] [Abstract][Full Text] [Related]
4. Structural basis for dimerization of the Grb10 Src homology 2 domain. Implications for ligand specificity.
Stein EG; Ghirlando R; Hubbard SR
J Biol Chem; 2003 Apr; 278(15):13257-64. PubMed ID: 12551896
[TBL] [Abstract][Full Text] [Related]
5. Backbone nuclear relaxation characteristics and calorimetric investigation of the human Grb7-SH2/erbB2 peptide complex.
Ivancic M; Spuches AM; Guth EC; Daugherty MA; Wilcox DE; Lyons BA
Protein Sci; 2005 Jun; 14(6):1556-69. PubMed ID: 15930003
[TBL] [Abstract][Full Text] [Related]
6. Interaction of the non-phosphorylated peptide G7-18NATE with Grb7-SH2 domain requires phosphate for enhanced affinity and specificity.
Gunzburg MJ; Ambaye ND; Del Borgo MP; Pero SC; Krag DN; Wilce MC; Wilce JA
J Mol Recognit; 2012 Jan; 25(1):57-67. PubMed ID: 22213451
[TBL] [Abstract][Full Text] [Related]
7. Solution structure of the human Grb7-SH2 domain/erbB2 peptide complex and structural basis for Grb7 binding to ErbB2.
Ivancic M; Daly RJ; Lyons BA
J Biomol NMR; 2003 Nov; 27(3):205-19. PubMed ID: 12975581
[TBL] [Abstract][Full Text] [Related]
8. Calorimetric investigation of phosphorylated and non-phosphorylated peptide ligand binding to the human Grb7-SH2 domain.
Spuches AM; Argiros HJ; Lee KH; Haas LL; Pero SC; Krag DN; Roller PP; Wilcox DE; Lyons BA
J Mol Recognit; 2007; 20(4):245-52. PubMed ID: 17705331
[TBL] [Abstract][Full Text] [Related]
9. Analysis of Grb7 recruitment by heregulin-activated erbB receptors reveals a novel target selectivity for erbB3.
Fiddes RJ; Campbell DH; Janes PW; Sivertsen SP; Sasaki H; Wallasch C; Daly RJ
J Biol Chem; 1998 Mar; 273(13):7717-24. PubMed ID: 9516479
[TBL] [Abstract][Full Text] [Related]
10. Grb7 SH2 domain structure and interactions with a cyclic peptide inhibitor of cancer cell migration and proliferation.
Porter CJ; Matthews JM; Mackay JP; Pursglove SE; Schmidberger JW; Leedman PJ; Pero SC; Krag DN; Wilce MC; Wilce JA
BMC Struct Biol; 2007 Sep; 7():58. PubMed ID: 17894853
[TBL] [Abstract][Full Text] [Related]
11. Grb7 is a downstream signaling component of platelet-derived growth factor alpha- and beta-receptors.
Yokote K; Margolis B; Heldin CH; Claesson-Welsh L
J Biol Chem; 1996 Nov; 271(48):30942-9. PubMed ID: 8940081
[TBL] [Abstract][Full Text] [Related]
12. Development of binding assays for the SH2 domain of Grb7 and Grb2 using fluorescence polarization.
Luzy JP; Chen H; Gril B; Liu WQ; Vidal M; Perdereau D; Burnol AF; Garbay C
J Biomol Screen; 2008 Feb; 13(2):112-9. PubMed ID: 18216394
[TBL] [Abstract][Full Text] [Related]
13. Discovery of a novel nonphosphorylated pentapeptide motif displaying high affinity for Grb2-SH2 domain by the utilization of 3'-substituted tyrosine derivatives.
Song YL; Peach ML; Roller PP; Qiu S; Wang S; Long YQ
J Med Chem; 2006 Mar; 49(5):1585-96. PubMed ID: 16509576
[TBL] [Abstract][Full Text] [Related]
14. Grb7-SH2 domain dimerisation is affected by a single point mutation.
Porter CJ; Wilce MC; Mackay JP; Leedman P; Wilce JA
Eur Biophys J; 2005 Jul; 34(5):454-60. PubMed ID: 15841400
[TBL] [Abstract][Full Text] [Related]
15. Identification of Tek/Tie2 binding partners. Binding to a multifunctional docking site mediates cell survival and migration.
Jones N; Master Z; Jones J; Bouchard D; Gunji Y; Sasaki H; Daly R; Alitalo K; Dumont DJ
J Biol Chem; 1999 Oct; 274(43):30896-905. PubMed ID: 10521483
[TBL] [Abstract][Full Text] [Related]
16. Human GRB-IRbeta/GRB10. Splice variants of an insulin and growth factor receptor-binding protein with PH and SH2 domains.
Frantz JD; Giorgetti-Peraldi S; Ottinger EA; Shoelson SE
J Biol Chem; 1997 Jan; 272(5):2659-67. PubMed ID: 9006901
[TBL] [Abstract][Full Text] [Related]
17. Direct association between the Ret receptor tyrosine kinase and the Src homology 2-containing adapter protein Grb7.
Pandey A; Liu X; Dixon JE; Di Fiore PP; Dixit VM
J Biol Chem; 1996 May; 271(18):10607-10. PubMed ID: 8631863
[TBL] [Abstract][Full Text] [Related]
18. The intertwining of structure and function: proposed helix-swapping of the SH2 domain of Grb7, a regulatory protein implicated in cancer progression and inflammation.
Pias S; Peterson TA; Johnson DL; Lyons BA
Crit Rev Immunol; 2010; 30(3):299-304. PubMed ID: 20370637
[TBL] [Abstract][Full Text] [Related]
19. Grb10 interacts differentially with the insulin receptor, insulin-like growth factor I receptor, and epidermal growth factor receptor via the Grb10 Src homology 2 (SH2) domain and a second novel domain located between the pleckstrin homology and SH2 domains.
He W; Rose DW; Olefsky JM; Gustafson TA
J Biol Chem; 1998 Mar; 273(12):6860-7. PubMed ID: 9506989
[TBL] [Abstract][Full Text] [Related]
20. Evidence for an interaction between the insulin receptor and Grb7. A role for two of its binding domains, PIR and SH2.
Kasus-Jacobi A; Béréziat V; Perdereau D; Girard J; Burnol AF
Oncogene; 2000 Apr; 19(16):2052-9. PubMed ID: 10803466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
